Continuous Glucose Monitoring Market Growth, Size, Trends Analysis- By Component, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Continuous Glucose Monitoring Market Introduction and Overview

According to SPER Market Research, 'Global Continuous Glucose Monitoring Market Size- By Component, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' states that the Global Continuous Glucose Monitoring Market is estimated to reach USD 34.93 billion by 2033 with a CAGR of 13.14%.

Continuous glucose monitoring is a great way to estimate blood glucose levels throughout the day and night. It is made up of three components: a tiny sensor, a sticky patch, and an implanted sensor. These sensors detect the glucose stage in the fluid between cells, which roughly corresponds to the glucose stage in the blood. The CGM machine similarly has three components: a sensor, a transmitter, and a software program.

The COVID-19 outbreak had a significant impact on the continuous glucose monitoring business. Initially, the market experienced a setback due to the start of lockdown and the strict controls imposed by authorities during the lockdown. Throughout the pandemic, continuous glucose monitoring (CGM) gained popularity for diabetes self-management and treatment.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Component, By End User.

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Companies Covered Abbott, Dexcom Inc, A. Menarini Diagnostics S.r.l, Ypsomed AG, F. Hoffmann-La Roche Ltd, Medtronic, Senseonics Holdings Inc, Medtrum Technologies, Nemaura Medical Inc.

Continuous Glucose Monitoring Market Segmentation:

By Component: Based on the Component, Global Continuous Glucose Monitoring Market is segmented as; Sensors, Durables (Receivers and Transmitter).

By End User: Based on the End User, Global Continuous Glucose Monitoring Market is segmented as; Hospital/Clinics, Home/Personal.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Product Code: MEDE2447

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Continuous Glucose Monitoring Market.

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Continuous Glucose Monitoring Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Continuous Glucose Monitoring Market

7. Global Continuous Glucose Monitoring Market, By Component (USD Million) 2020-2033

7.1. Global Continuous Glucose Monitoring Market Size, Share and Forecast, By Component, 2020-2026
7.2. Global Continuous Glucose Monitoring Market Size, Share and Forecast, By Component, 2027-2033
7.3. Sensors
7.4. Durables (Receivers and Transmitters)

8. Global Continuous Glucose Monitoring Market, By End User (USD Million) 2020-2033

8.1. Global Continuous Glucose Monitoring Market Size, Share and Forecast, By End User, 2020-2026
8.2. Global Continuous Glucose Monitoring Market Size, Share and Forecast, By End User, 2027-2033
8.3. Hospital/Clinics
8.4. Home/Personal

9. Global Continuous Glucose Monitoring Market Forecast, 2020-2033 (USD Million)

9.1. Global Continuous Glucose Monitoring Market Size and Market Share

10. Global Continuous Glucose Monitoring Market, By Region, 2020-2033 (USD Million)

10.1. Global Continuous Glucose Monitoring Market Size and Market Share By Region (2020-2026)
10.2. Global Continuous Glucose Monitoring Market Size and Market Share By Region (2027-2033)
10.3. Asia-Pacific
- 10.3.1. Australia
- 10.3.2. China
- 10.3.3. India
- 10.3.4. Japan
- 10.3.5. South Korea
- 10.3.6. Rest of Asia-Pacific
10.4. Europe
- 10.4.1. France
- 10.4.2. Germany
- 10.4.3. Italy
- 10.4.4. Spain
- 10.4.5. United Kingdom
- 10.4.6. Rest of Europe
10.5. Middle East and Africa
- 10.5.1. Kingdom of Saudi Arabia
- 10.5.2. United Arab Emirates
- 10.5.3. Qatar
- 10.5.4. South Africa
- 10.5.5. Egypt
- 10.5.6. Morocco
- 10.5.7. Nigeria
- 10.5.8. Rest of Middle-East and Africa
10.6. North America
- 10.6.1. Canada
- 10.6.2. Mexico
- 10.6.3. United States
10.7. Latin America
- 10.7.1. Argentina
- 10.7.2. Brazil
- 10.7.3. Rest of Latin America

11. Company Profile

11.1. Abbott
- 11.1.1. Company details
- 11.1.2. Financial outlook
- 11.1.3. Product summary
- 11.1.4. Recent developments
11.2. Dexcom Inc
- 11.2.1. Company details
- 11.2.2. Financial outlook
- 11.2.3. Product summary
- 11.2.4. Recent developments
11.3. A. Menarini Diagnostics S.r.l
- 11.3.1. Company details
- 11.3.2. Financial outlook
- 11.3.3. Product summary
- 11.3.4. Recent developments
11.4. Ypsomed AG
- 11.4.1. Company details
- 11.4.2. Financial outlook
- 11.4.3. Product summary
- 11.4.4. Recent developments
11.5. F. Hoffmann-La Roche Ltd
- 11.5.1. Company details
- 11.5.2. Financial outlook
- 11.5.3. Product summary
- 11.5.4. Recent developments
11.6. Medtronic
- 11.6.1. Company details
- 11.6.2. Financial outlook
- 11.6.3. Product summary
- 11.6.4. Recent developments
11.7. Senseonics Holdings Inc
- 11.7.1. Company details
- 11.7.2. Financial outlook
- 11.7.3. Product summary
- 11.7.4. Recent developments
11.8. Medtrum Technologies
- 11.8.1. Company details
- 11.8.2. Financial outlook
- 11.8.3. Product summary
- 11.8.4. Recent developments
11.9. Nemaura Medical Inc
- 11.9.1. Company details
- 11.9.2. Financial outlook
- 11.9.3. Product summary
- 11.9.4. Recent developments
11.10. Others